HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus
November 15, 2024 08:00 ET
|
HealthLynked Corp
NAPLES, Fla., Nov. 15, 2024 (GLOBE NEWSWIRE) -- via IBN – HealthLynked Corp. (OTCQB: HLYK), a leader in healthcare networking and technology innovation, today announced financial results for the...
Altran Expands Americas Life Sciences Business, Plans Digital Therapeutics Innovation Center in Greater Boston
October 17, 2019 06:30 ET
|
Altran
NEW YORK, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Altran, the world leader in engineering and R&D services, announced today a significant expansion of its Life Sciences business in the Americas,...
Adhera Therapeutics Announces Termination of Tender Offer for Preferred Stock
September 26, 2019 16:19 ET
|
Adhera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, NC, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and...
PrescribeWellness Names Patty Kumbera as Chief Operating Officer
August 21, 2018 06:00 ET
|
PrescribeWellness
Irvine, California, Aug. 21, 2018 (GLOBE NEWSWIRE) -- PrescribeWellness, a leading cloud-based patient relationship management solutions company that inspires collaboration between pharmacies,...
Qu Biologics invited to present research data at inaugural Crohn’s and Colitis Congress
December 19, 2017 12:45 ET
|
Qu Biologics
VANCOUVER, British Columbia, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...
Patient-Centric Pharmaceutical Strategies: Drug Companies Allocate Broad Range of Responsibilities to Dedicated Teams
September 01, 2016 08:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 01, 2016) - Patient centricity is no longer a buzzword in the pharmaceutical industry. The industry's transition away from brand-focused messages...